Nutropin (somatropin-rDNA origin)


Approval Status
Approved December 1997

Treatment for
growth hormone deficiency

Possible similar drugs

Diabetes / Endocrinology

The liquid formulation of Nutropin (somatropin injection) has been approved for the replacement of endogenous growth hormone in adult patients with growth hormone deficiency. The product is currently indicated for pediatric growth hormone deficiency and chronic renal insufficiency.

Nutropin (somatropin-rDNA origin) Drug Information

The Nutropin (somatropin-rDNA origin) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top